Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

How to Sell a Drug Before it is Approved
A European "named patient program" might be an option.

Pharmaceutical marketers can generate significant interest in a drug before it is officially launched. This is often done by supporting educational CME programs for physicians, employing key opinion leaders, sponsoring satellite symposia at major medical meetings, and publishing clinical trial results.

However, did you know that you can also sell a drug before it is launched? Dr. Gene Emmer, President of Med Services Europe B.V., an Amsterdam-based consultancy focused on sales, marketing, and business development for the medical industry, advises his start-up, cash hungry, biotech companies to consider if a European "named patient program" might be an option.

Topics covered include:

  • Significant Revenues Are Possible
  • Other Benefits of Named Patient Programs
  • Communication Yes, Marketing No
  • European Marketing Expertise Required

Read this article now. It's FREE...

Download PDF file

Issue: Vol. 4, No. 3: March 2005
Word Count: 1121

Find other articles in related Topic Areas:

Vol 4, #3 Contents

Contact Information
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.